Perfuze
  • Home
  • Acute Ischemic Stroke
  • Unmet Clinical Need
  • Our Solution
  • The Team
  • Our Company
  • Careers
  • IN THE NEWS
  • Contact Us
  • Privacy Policy
Perfuze
Unit 6, Galway Business Park, Dangan Galway, H91 W7CP, Ireland
News Signup

Press

IN THE NEWS

March 2022

Neurovascular Company Perfuze Raises €22.5m...

Series A for New Stroke Treatment. Perfuze Raises €22.5m

Read More
May 2021

Perfuze secures CE Mark on first product

First five patients successfully treated

Read More
March 2021

Published paper - JNIS

Millipede 088 optimizes distal flow control resulting in potential improved revascularization rates

Read more
December 2020

Perfuze wins €4.4m DTIF Grant

Minister Humphreys announces €65m for 16 ground-breaking projects

Read more
December 2020

Perfuze wins IMDA award

Perfuze wins Emerging Medtech Company of the Year

Read more
June 2020

Published paper - JNIS

Preclinical evaluation of Millipede 088 intracranial aspiration catheter

Read publication
September 2019

Medtech Strategist Interview

Ischemic Stroke: The First Pass Effect

Read publication
August 2019

FDA Breakthrough Device Designation

Perfuze Receives Breakthrough Device Designation Status from U.S. Food and Drug Administration (FDA)

Read more
June 2019

€2.5m Horizon 2020 Grant award

Perfuze receives €2.5m receive European Innovation Council funding

Read more
January 2019

€3m Seed Round investment

Irish Startup Medtech Company has closed a €3 Million in Seed Investment Round

Read more
  • Contact Us
  • Sitemap
  • Location
  • Privacy Policy
News Signup
Perfuze
Unit 6, Galway Business Park, Dangan
Galway, H91 W7CP, Ireland
Get Directions
© 2020 Perfuze Ltd. All rights reserved. Created by Aró
Our R&D Grant Partners
Disruptive Technologies Innovation Fund Horizon 2020
Our Investors
EQT Life Sciences Seroba Earlybird MedFocus Enterprise Ireland